Pharmacists optimize dopaminergic therapy, mitigate medication-induced psychosis, and guide antipsychotic selection to improve outcomes in Parkinson disease psychosis.
Sabrina Flores, 2026 PharmD Candidate
Advertisement
Articles by Sabrina Flores, 2026 PharmD Candidate
Pimavanserin offers a serotonin-targeted option for Parkinson disease psychosis that improves hallucinations and delusions with minimal impact on motor symptoms.
Advertisement
Latest Updated Articles
Understanding Pimavanserin: A Novel Approach to Parkinson Disease PsychosisPublished: December 25th 2025 | Updated:
The Role of the Pharmacist in the Management of Psychosis in Parkinson DiseasePublished: December 30th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Nipah Outbreak in India Poses Low Global Risk Despite Lack of Approved Treatments
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
5